Evidence map›Paper›PMID 26528358›Full record

ArticleArchives of medical science : AMS2015

Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.

Hayri Kertmen, Bora Gürer, Erdal Resit Yilmaz, Mehmet Ali Kanat, Ata Türker Arikok, Berrin Imge Ergüder, Askin Esen Hasturk, Julide Ergil, Zeki Sekerci

Open access · greenAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hayri KertmenMinistry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Neurosurgery Clinic, Ankara, Turkey.
Bora GürerMinistry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Neurosurgery Clinic, Ankara, Turkey.
Erdal Resit YilmazMinistry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Neurosurgery Clinic, Ankara, Turkey.
Mehmet Ali KanatMinistry of Health, Refik Saydam National Public Health Agency, Ankara, Turkey.
Ata Türker ArikokDepartment of Pathology, Ministry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
Berrin Imge ErgüderDepartment of Biochemistry, Ankara University, Ankara, Turkey.
Askin Esen HasturkDepartment of Neurosurgery, Ministry of Health, Oncology Training and Research Hospital, Ankara, Turkey.
Julide ErgilDepartment of Anesthesiology, Ministry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
Zeki SekerciMinistry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Neurosurgery Clinic, Ankara, Turkey.
Ministry of Health · TRAnkara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn this study, we tried to determine whether darbepoetin-α would protect the brain from oxidative stress and apoptosis in a rat traumatic brain injury model. MATERIAL AND

methodsThe animals were randomized into four groups; group 1 (sham), group 2 (trauma), group 3 (darbepoetin α), group 4 (methylprednisolone). In the sham group only the skin incision was performed. In all the other groups, a moderate traumatic brain injury modelwas applied.

resultsFollowing trauma both glutathione peroxidase, superoxide dismutase levels decreased (p < 0.001 for both); darbepoetin-α increased the activity of both antioxidant enzymes (p = 0.001 and p < 0.001 respectively). Trauma caused significant elevation in the nitric oxide synthetase and xanthine oxidase levels (p < 0.001 for both). Administration of darbepoetin-α significantly decreased the levels of nitric oxide synthetase and xanthine oxidase (p < 0.001 for both). Also, trauma caused significant elevation in the nitric oxide levels (p < 0.001); darbepoetin-α administration caused statistically significant reduction in the nitric oxide levels (p < 0.001). On the other hand, malondialdehyde levels were increased following trauma (p < 0.001), and darbepoetin α significantly reduced the malondialdehyde levels (p < 0.001). Due to the elevated apoptotic activity following the injury, caspase-3 activity increased significantly. Darbepoetin-α treatment significantly inhibited apoptosis by lowering the caspase-3 activity (p < 0.001). In the darbepoetin group, histopathological score was lower than the trauma group (p = 0.016).

conclusionsIn this study, darbepoetin-α was shown to be at least as effective as methylprednisolone in protecting brain from oxidative stress, lipid peroxidation and apoptosis.

Indexed as

antiapoptosisantioxidationdarbepoetin-αmethylprednisoloneneuroprotectionrattraumatic brain injury

Identifiers

PMID26528358
PMCPMC4624756
OpenAlexW2145064497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.